NCT04829929 - Evaluation od Safety and Performance of the Omega™ LAA (Left Atrial Appendage) Occluder and Omega™ Delivery System in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

November 17, 2020

Primary Completion Date

May 30, 2023

Study Completion Date

November 17, 2023

Conditions

Non-Valvular Atrial Fibrillation

Interventions

DEVICE

Omega™LAA Occluder implantation

Left Atrial Appendage closure for patients with non-valvular atrial fibrillation (NVAF) and high bleeding risk by Omega™LAA Occluder using Omega™ Delivery System

Trial Locations (9)

2100

RECRUITING

Rigshospitalet, Kardiologisk klinik B 2011, Copenhagen

47005

RECRUITING

Instituto de Ciencias del Corazón (ICICOR) . Hospital Clínico Universitario, Valladolid

60389

RECRUITING

CardioVasculäres Centrum, Seckbacher Landstrasse 65, Frankfurt

60431

RECRUITING

Cardioangiologisches Centrum Bethanien, Frankfurt

12203 Berlin

RECRUITING

Charité - University Medicine Berlin - Campus Benjamin Franklin, Berlin

04289

RECRUITING

Herzzentrum Leipzig, Leipzig

00128

RECRUITING

Università Campus Biomedico Roma, Rome

58-182, 37007

RECRUITING

Complejo Hospitalario de Salamanca, Salamanca

BN2 1ES

RECRUITING

University Hospitals Sussex NHS Foundation Trust Clinical Research Facility, Brighton